The global breast retractors market size was estimated at USD 336.9 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.33% from 2023 to 2030. The increasing preference for aesthetic procedures and increasing incidence of breast cancer cases are the major factors contributing to the growth. Increasing adoption of minimally invasive procedures and increased procedural volume are other factors driving the growth. A large number of elderly women are more susceptible to breast cancer with the aging population in many nations as a result of longer life expectancies. Breast cancer risk rises with age, and women 60 and older are more likely to have the disease than younger women to be diagnosed. In their lifetimes, older women may have been exposed for a longer period to breast cancer risk factors such as hormone treatments, family history, obesity, and alcohol use.
The possibility of acquiring breast cancer in later life may rise with cumulative exposure to these risk factors. The two main risk factors for breast cancer after menopause are an unhealthy lifestyle and being overweight. For instance, as per the International Agency for Research on Cancer estimates by 2025, there will be about 50,550,287 breast cancer cases globally from 19,292,789 in 2020. Thus, the increasing number of cancer cases can lead to the adoption of more cancer surgeries and treatments creating a positive impact on the use of retractor devices.
The increasing prevalence of breast cancer worldwide, particularly in industrialized countries, and its high mortality, particularly in developing countries, are key factors driving the demand for breast surgery. The desire for better surgical tools, including breast surgery retractors, is thus being driven by this. The demand for breast surgery retractors is growing as less invasive treatments for breast cosmetic surgery become more popular. The market is being helped by a significant increase in surgeries such as mastectomy and lumpectomy as a result of women's increased knowledge of the hazards associated with breast cancer.
The increasing success rate and effectiveness of plastic surgeries such as breast reduction surgeries and breast reconstruction results in the increasing demand for breast reactors, which has a positive impact on the market. Women adopt such surgeries to enhance breast size for reconstruction applications following mastectomy, which is expected to drive market growth in the near future.
Based on type, the handheld segment held the largest market share of around 69.91 % in 2022. Open procedures are typically performed with handheld retractors by surgeons. Moreover, a clear and uninterrupted view of the operative area is made possible with the use of handheld breast retractors. The ability to see and access the target structures is facilitated by holding back breast tissue, which is essential for accurate and secure surgical treatments. To reduce tissue stress during surgery, handheld retractors are suitable. Controlled retraction can be accomplished with their delicate grip and customizable features without putting too much pressure on the surrounding tissues.
The self-retaining segment is anticipated to grow at the fastest CAGR during the forecast period. Self-retaining retractors allow the surgeon to carry out the treatment with just one hand. In a variety of breast procedures, such as breast reconstruction, augmentation, reduction, and breast cancer surgery, this improves surgical precision and control. Self-retaining retractors are made in a way that provides the best possible access to the surgical site. To provide a good view and easy access to the target tissues, surgeons can adjust the retraction angle and position to fit the particular requirements of the treatment. Self-retaining retractors can reduce operating room time since surgical assistants can be used for other crucial activities. This may result in more effective processes and faster surgical times.
Based on usage, the reusable segment held the largest market share of around 63.77 % in 2022. Reusable retractors are more affordable in the long run than disposable ones. Even while the initial investment may be more expensive, the fact that they can be used more than once can lead to significant cost savings, especially for healthcare facilities that perform a lot of breast surgeries. The performance and structural integrity of high-quality reusable retractors are built to survive repeated sterilization and use. The instruments' long-term effectiveness is ensured by their longevity. Moreover, as compared to disposable devices, reusable ones produce less medical waste. Healthcare facilities may reduce their environmental impact and support sustainability initiatives by repeatedly utilizing and sterilizing retractors.
The disposable segment is expected to grow at the fastest CAGR during the forecast period. Infection management and lowering the risk of healthcare-associated infections (HAIs) are becoming increasingly important in hospital settings. Disposable retractors are a preferable option for treatments where infection is a concern since they are single-use and sterile, which helps reduce the danger of cross-contamination. The surgical procedure is simplified by the use of disposable breast retractors, which do not require frequent cleaning, sterilization, or maintenance. Such devices help surgical teams to save time and perform operations more quickly. Disposable tools offer a constant level of sterility and quality. Since every retractor is the same, the surgical setup is less chaotic and more stable.
Based on application, the breast augmentation segment held the largest market share of around 26.60% in 2022. Breast augmentation has become safer and more widely available due to improvements in surgical methods and technology. Furthermore, better outcomes and quicker recovery periods have been made possible by surgical breakthroughs such as the use of cohesive silicone gel implants and better incision techniques. For instance, as per the Aesthetic Plastic Surgery National Databank statistics (2020–2021), about 364,753 breast augmentation surgeries were performed by 2021 in the U.S. The report demonstrated that, in the field of plastic surgery, breast augmentation is one of the most popular and frequently carried out treatments. Greater awareness and education about breast augmentation and its benefits have made potential candidates more informed and comfortable with the procedure.
The lumpectomy segment is expected to grow at the fastest CAGR during the forecast period. Smaller tumors can now be successfully treated with lumpectomy rather than mastectomy (total removal of the breast) due to recent developments in the field of breast cancer treatment, such as chemotherapy, targeted medicines, and radiation therapy. Due to this, the number of lumpectomy procedures has increased. Moreover, as breast-conserving surgery preserves a more natural-looking breast appearance than mastectomy, many women are undergoing such procedures. Furthermore, retractors and other minimally invasive surgical equipment have made lumpectomy treatments more practical and less intrusive. These methods frequently lead to smaller incisions and quicker recoveries.
Based on end-use, the hospitals held the largest market share of around 47.30% in 2022. Retractor-assisted breast surgeries are frequently carried out by trained surgical teams in hospitals, including inpatient and outpatient settings. The sterile, regulated atmosphere that hospitals provide is ideal for breast surgery. To guarantee ideal visualization and access to the surgical area, these procedures frequently require specific equipment, such as surgical retractors. To carry out these procedures successfully and safely, surgeons, anesthesiologists, nurses, and other medical experts collaborate in hospital settings. Hospitals also have the equipment necessary to handle any potential issues and offer thorough treatment to patients having breast surgery.
The ambulatory surgical centers segment is expected to grow at the fastest CAGR during the forecast period. The number of breast operations performed in ambulatory surgery centers (ASCs) has increased as a result of a number of factors, including improvements in anesthetic, shorter recovery times, and a move toward outpatient care. Currently, many breast procedures that require the use of retractors can be carried out effectively and securely in ASCs. ASCs frequently have lower overhead expenses than hospitals, which could result in lower patient personal expenses and lower healthcare costs overall. Breast operations performed as outpatient procedures are now safer and more practical due to advances in anesthetic technology.
North America dominated the market for breast retractors with a share of 44.48 % in 2022 due to the rise in cosmetic surgery operations and public awareness of plastic surgery. The diseased population (those with breast cancer) is becoming more aware of the accessibility of surgical techniques in the area and the widespread acceptability of aesthetic procedures. According to the American Cancer Society, breast cancer is the most common cancer among women to be diagnosed in the nation. A further factor driving interest in surgical breast retractor devices in the region is the rise in breast reconstruction surgeries. With the advent of cutting-edge technologies such as 3D printing and robotics, the market for surgical breast retractors in this region is growing. Also, the presence of market players such as COOPERSURGICAL, INC.; Artisan Medical; Thompson Surgical; and Medline Industries LP.; involved in developing advanced products are expected to boost the regional market growth.
Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The increased adoption of breast cancer screening programs, expanding breast health awareness, and rising demand for minimally invasive surgeries are driving the market expansion in the region. Moreover, the improving healthcare infrastructure, increasing medical surgeries, along with the government agreements for enhancing the medical device portfolio are expected to have a positive impact on the growth. For instance, in March 2022, a USD 42 billion investment and a five-year financial plan in India, were approved by the prime ministers of India and Japan, for a collaborative effort between both countries in the production of medical devices.
The key players are focusing on the launch of innovative types of medical devices, growth strategies, technological advancements, and regulatory approvals for the treatments associated with breast surgeries with the application of retractors. For instance, in April 2023, JUNE Medical announced an agreement with a prominent U.S.-based hospital group to provide Galaxy II self-retaining surgical retractors to more than 1,600 hospitals across the U.S. This device represents a significant advancement in enhancing the safety and convenience of surgical retraction for both patients and medical personnel. Its ergonomic design revolutionizes the surgical process, making it particularly well-suited for group purchasing organizations looking to provide their hospitals with top-notch, cost-effective products. Some prominent players in the global breast retractors market include:
Medtronic
Stille
Artisan Medical Industries, LP.
COOPER SURGICAL, INC.
Stryker
Integra LifeSciences
Accurate Surgical & Scientific Instruments Corporation
Gulmaher Surgico
Jalal Surgical
Mahr Surgical
Thompson Surgical
Artisan Medical
Surtex Instruments Limited
Hayden Medical Inc.
Report Attribute |
Details |
Market size value in 2023 |
USD 352.16 million |
Revenue forecast in 2030 |
USD 506.49 million |
Growth rate |
CAGR of 5.33% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million, and CAGR from 2023 to 2030 |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Report coverage |
Revenue, competitive landscape, growth factors, and trends |
Segments Covered |
Type, usage, application, end-use, region |
Key companies profiled |
Medtronic, Stille; Artisan Medical Industries, LP.; COOPER SURGICAL, INC.; Stryker; Integra LifeSciences, Accurate Surgical & Scientific Instruments Corporation; Gulmaher Surgico; Jalal Surgical; Mahr Surgical; Thompson Surgical; Artisan Medical, Surtex Instruments Limited; Hayden Medical Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global level, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global breast retractors market report based on type, usage, application, end-use, and region:
Type Outlook (Revenue, USD Million, 2018 - 2030)
Handheld
Self-retaining
Usage Outlook (Revenue, USD Million, 2018 - 2030)
Reusable
Disposable
Application Outlook (Revenue, USD Million, 2018 - 2030)
Mastectomy
Breast Reconstruction
Breast Augmentation
Lumpectomy
Breast Reduction
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global breast retractors market size was estimated at USD 336.9 million in 2022 and is expected to reach USD 352.16 million in 2023.
b. The global breast retractors market is expected to grow at a compound annual growth rate of 5.33% from 2023 to 2030 to reach USD 506.49 million by 2030
b. Reusable segment dominated the market by capturing market share of around 63.77 % in 2022. Reusable retractors are more affordable in the long run than disposable ones.
b. Some key players operating in the breast retractors market include Medtronic, Stille, Artisan Medical Industries, LP., COOPERSURGICAL, INC., Stryker, Integra LifeSciences, Accurate Surgical & Scientific Instruments Corporation, Gulmaher Surgico, Jalal Surgical, Mahr Surgical, Thompson Surgical, Artisan Medical, Surtex Instruments Limited, Hayden Medical Inc.
b. Key factors that are driving the breast retractors market growth include growing incidence of breast cancer, and growing preference for aesthetic procedures.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."